Skip Navigation


ToxSci Advance Access originally published online on February 22, 2006
Toxicological Sciences 2006 91(1):140-149; doi:10.1093/toxsci/kfj141
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
91/1/140    most recent
kfj141v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (22)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Letschert, K.
Right arrow Articles by Keppler, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Letschert, K.
Right arrow Articles by Keppler, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Molecular Characterization and Inhibition of Amanitin Uptake into Human Hepatocytes

Katrin Letschert*, Heinz Faulstich{dagger}, Daniela Keller* and Dietrich Keppler*,1

* Division of Tumor Biochemistry, German Cancer Research Center, 69120 Heidelberg, Germany; and {dagger} Bioorganic Research Group, Max-Planck-Institute for Medical Research, D-69120 Heidelberg, Germany

Received December 15, 2005; accepted February 16, 2006

Amatoxins are the main poison of the green death cap (Amanita phalloides) and among the most dangerous natural toxins causing hepatic failure. A possible therapeutic approach is the inhibition of the transporting systems mediating the uptake of amatoxins into human hepatocytes, which, however, have yet to be identified. In the current study we tested whether members of the organic anion–transporting polypeptide (OATP) family, localized in the sinusoidal membranes of human hepatocytes, are involved in amatoxin uptake. For this, Madin Darby canine kidney strain II (MDCKII) cells stably expressing human OATP1B3, OATP2B1, or OATP1B1, were assayed for the uptake of 3H-labeled O-methyl-dehydroxymethyl-{alpha}-amanitin. Under our conditions, only OATP1B3 was able to transport amanitin with a Km value of 3.7µM ± 0.6µM. Accordingly, toxin uptake was inhibited by OATP1B3 substrates and inhibitors (cyclosporin A, rifampicin, the quinoline derivatives MK571 ([(3-(3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)((3-dimethylamino-3-oxopropyl)thio)methyl)thiopropanoic acid]) and montelukast, the cholecystokinin octapeptide (CCK-8), paclitaxel, and bromosulfophthalein), as well as by some antidotes used in the past for the treatment of human amatoxin poisoning (silibinin dihemisuccinate, penicillin G, prednisolone phosphate, and antamanide). These transport studies are in line with viability assays monitoring the toxic effect of amanitin on the transfected MDCKII cells. Further support for amatoxin transport was found in primary human hepatocytes, expressing OATP1B3, OATP2B1, and OATP1B1, where CCK-8, a substrate specific for OATP1B3, prevented the fragmentation of nucleoli, a lesion typical for amanitin action. In conclusion, we have identified OATP1B3 as the human hepatic uptake transporter for amatoxins; moreover, substrates and inhibitors of OATP1B3, among others rifampicin, may be useful for the treatment of human amatoxin poisoning.

Key Words: organic anion transporter 1B3; rifampicin; hepatocellular transport; amanitin transport; amanitin poisoning.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
O. Janneh, B. Chandler, R. Hartkoorn, W. S. Kwan, C. Jenkinson, S. Evans, D. J. Back, A. Owen, and S. H. Khoo
Intracellular accumulation of efavirenz and nevirapine is independent of P-glycoprotein activity in cultured CD4 T cells and primary human lymphocytes
J. Antimicrob. Chemother., November 1, 2009; 64(5): 1002 - 1007.
[Abstract] [Full Text] [PDF]

Home page
 In VivoHome page
J. MAGDALAN, A. OSTROWSKA, A. PIOTROWSKA, I. IZYKOWSKA, M. NOWAK, A. SZELAG, and P. DZIEGIEL
Failure of Benzylpenicillin, N-Acetylcysteine and Silibinin to Reduce {alpha}-Amanitin Hepatotoxicity
In Vivo, May 1, 2009; 23(3): 393 - 399.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
H. Lu, S. Choudhuri, K. Ogura, I. L. Csanaky, X. Lei, X. Cheng, P.-z. Song, and C. D. Klaassen
Characterization of Organic Anion Transporting Polypeptide 1b2-null Mice: Essential Role in Hepatic Uptake/Toxicity of Phalloidin and Microcystin-LR
Toxicol. Sci., May 1, 2008; 103(1): 35 - 45.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H. E. Hallen, H. Luo, J. S. Scott-Craig, and J. D. Walton
From the Cover: Gene family encoding the major toxins of lethal Amanita mushrooms
PNAS, November 27, 2007; 104(48): 19097 - 19101.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
O. Janneh, E. Jones, B. Chandler, A. Owen, and S. H. Khoo
Inhibition of P-glycoprotein and multidrug resistance-associated proteins modulates the intracellular concentration of lopinavir in cultured CD4 T cells and primary human lymphocytes
J. Antimicrob. Chemother., November 1, 2007; 60(5): 987 - 993.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
M. Komatsu, T. Furukawa, R. Ikeda, S. Takumi, Q. Nong, K. Aoyama, S.-i. Akiyama, D. Keppler, and T. Takeuchi
Involvement of Mitogen-Activated Protein Kinase Signaling Pathways in Microcystin-LR-Induced Apoptosis after its Selective Uptake Mediated by OATP1B1 and OATP1B3
Toxicol. Sci., June 1, 2007; 97(2): 407 - 416.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. L. Lam, S. B. Shugarts, H. Okochi, and L. Z. Benet
Elucidating the Effect of Final-Day Dosing of Rifampin in Induction Studies on Hepatic Drug Disposition and Metabolism
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 864 - 870.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.